Cytotoxic Drugs Contract Manufacturing Market Outlook and Opportunities in Grooming Regions 2027

Global Cytotoxic Drugs Contract Manufacturing Market

Global Cytotoxic Drugs Contract Manufacturing Market, by Production Scale (Laboratory Scale, Industrial Scale, and Pilot Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), had a market valuation of US$ 6,285.2 million in 2018, and is projected to grow at a CAGR of 9.1 percent during the forecast period (2019-2027), as mentioned in a new report published by Coherent Market Insights.

Drivers

Authorities of emerging markets such as India are focused on measures to boost domestic demand. The Department of Pharmaceuticals, which is part of the Ministry of Chemicals and Fertilizers, announced a ‘max customs duty’ in August 2017 and suggested the establishment of bulk drug parks to boost domestic demand. Moreover, the Asia Pacific region’s rapid growth in the pharmaceutical sector is projected to drive the growth of the global cytotoxic drug contract manufacturing market over the forecast period. As per the Indian Brand Equity Foundation (IBEF) in September 2019, the Indian pharmaceutical industry is projected to cross US$ 55 billion by 2020.

Get Sample Here

Over the forecast period, the global cytotoxic drugs contract manufacturing market is expected to rise due to increased investment by market players to extend their service and product offerings. In October 2017, Lonza Group opened the Lonza Collaborative Innovation Center (CIC) in Haifa, Israel’s new Life Science Park. Lonza hopes to use this to speed up leading R&D program around the Pharma & Biotech market, as well as tap into potentially disruptive biological and manufacturing capacities.

Browse 38 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on ‘Cytotoxic Drugs Contract Manufacturing Market’- Global Forecast to 2027, by Production Scale (Laboratory Scale, Industrial Scale, and Pilot Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis

Due to the implementation of growth strategies such as product launches, acquisitions, and facility expansion by market players in the region to increase their market presence, North America is projected to dominate the global cytotoxic drugs contract manufacturing market during the forecast period. Cambrex, a leading small molecule API contract producer, expanded its Charles City, Iowa manufacturing facility in 2016, adding 1,000 gallon and 4,000 gallon glass-lined reactors to the 7,500-square-foot facility.

In addition, market participants are focusing on partnership and acquisition strategies to extend their market reach and improve facilities in the region, which is expected to fuel growth of the global cytotoxic drugs contract manufacturing market during the forecast period. CordenPharma International, a contract provider of small-molecule APIs and drug products, purchased a Hospira Boulder plant from Pfizer Inc., a 54,000-square-foot API manufacturing facility in Colorado, U.S., in November 2017 to expand its high-potency manufacturing capability. The new facility will specialize in the growth, scale-up, optimization, and production of highly potent and cytotoxic/cytostatic APIs from development to commercialization, as per the expansion plan.

Key Takeaways

Due to growing adoption of partnership and acquisition strategies by key players and the rising pattern of contract manufacturing, the global cytotoxic drugs contract manufacturing market is projected to grow at a CAGR of 9.1 percent over the forecast period. CDMOs (Contract research and manufacturing organizations) play a critical role in accelerating the growth of novel small molecule drug candidates, as these critical development tasks are often outsourced to CDMOs.

Due to various growth strategies of market players, the liquid segment retained a leading spot in the global cytotoxic drugs contract manufacturing market in 2018. STA Pharmaceutical, a WuXi AppTec subsidiary, signed an investment agreement with the Shanghai government in April 2018 to construct a new research and development (R&D) center for APIs and intermediates adjacent to the company’s current Jinshan drug-substance manufacturing facility.

In 2018, the intravenous sector dominated the global cytotoxic drugs contract manufacturing market, due to companies concentrating on expanding their manufacturing facilities for sterile injectable and API supply in order to expand their customer base and meet their demand. Piramal Pharma Solutions expanded its manufacturing capabilities in Lexington, Kentucky, in March 2017. Installation of a new high-speed vial filling line, expansion of the state-of-the-art laboratories, and associated utility support are all part of the new facility.

Key companies contributing in the global cytotoxic drugs contract manufacturing market are AbbVie Contract Manufacturing, CordenPharma International, BSP Pharmaceuticals, SAFC Pharma, Evonik Industries AG, Evotec, Piramal Group, Lonza Group, Dishman Group, Pierre Fabre Laboratories, WuXi AppTec Ltd., Novasep Holding SAS, Baxter Biopharma Solutions, Albany Molecular Research Inc., Catalent, Inc., and Cambrex Corporation.

Companies operating in the global cytotoxic drugs contract manufacturing market include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3175

Cytotoxic Drugs Contract Manufacturing Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group

Main points in Cytotoxic Drugs Contract Manufacturing Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Cytotoxic Drugs Contract Manufacturing Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Cytotoxic Drugs Contract Manufacturing Industry Impact

Chapter 2 Global Cytotoxic Drugs Contract Manufacturing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cytotoxic Drugs Contract Manufacturing (Volume and Value) by Type
2.3 Global Cytotoxic Drugs Contract Manufacturing (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Cytotoxic Drugs Contract Manufacturing Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 6 East Asia Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 7 Europe Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 8 South Asia Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 9 Southeast Asia Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 10 Middle East Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 11 Africa Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 12 Oceania Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 13 South America Cytotoxic Drugs Contract Manufacturing Market Analysis
Chapter 14 Company Profiles and Key Figures in Cytotoxic Drugs Contract Manufacturing Business
Chapter 15 Global Cytotoxic Drugs Contract Manufacturing Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com